316 related articles for article (PubMed ID: 28958922)
1. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.
He XC; Zhang XX; Zhao JN; Liu Y; Yu CB; Yang GR; Li HC
Medicine (Baltimore); 2016 Apr; 95(15):e3336. PubMed ID: 27082586
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China.
Guo Q; Pan Y; Yang Z; Liu R; Xing L; Peng Z; Zhu C
PLoS One; 2016; 11(3):e0151303. PubMed ID: 26959480
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
5. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
[TBL] [Abstract][Full Text] [Related]
6. Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020.
Song WM; Li SJ; Liu JY; Fu Q; Xu TT; Tao NN; Zhang QY; Liu SQ; An QQ; Zhu XH; Liu Y; Yu CB; Li YF; Dong J; Li HC
BMJ Open; 2022 Jul; 12(7):e059149. PubMed ID: 35902191
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
8. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Liu Z; Shilkret KL; Finelli L
Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
[TBL] [Abstract][Full Text] [Related]
11. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
[TBL] [Abstract][Full Text] [Related]
12. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
13. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
[TBL] [Abstract][Full Text] [Related]
14. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019.
Song WM; Guo J; Xu TT; Li SJ; Liu JY; Tao NN; Liu Y; Zhang QY; Liu SQ; An QQ; Li YF; Yu CB; Dong JH; Li HC
BMC Pulm Med; 2021 Dec; 21(1):399. PubMed ID: 34872558
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China.
Li Q; Zhao G; Wu L; Lu M; Liu W; Wu Y; Wang L; Wang K; Qian HZ; Xie L
Antimicrob Resist Infect Control; 2018; 7():61. PubMed ID: 29744042
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Drug Resistance Pattern of
Mohammed KAS; Khudhair GS; Al-Rabeai DB
Pol J Microbiol; 2022 May; 71(2):205-215. PubMed ID: 35675816
[TBL] [Abstract][Full Text] [Related]
17. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018.
Song WM; Li YF; Ma XB; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; Yu CB; Gao L; Cui LL; Li HC
Respir Res; 2019 Oct; 20(1):223. PubMed ID: 31627757
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
Pradipta IS; Van't Boveneind-Vrubleuskaya N; Akkerman OW; Alffenaar JC; Hak E
Antimicrob Resist Infect Control; 2019; 8():115. PubMed ID: 31338162
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
